Unraveling the Mystery of Who Holds the Crown as the Best Dribbler Across Europe Today

Understanding Egg Reserve at Age 35

Many women wonder how fertility shifts in their thirties, especially when thinking about future family planning. While it’s impossible to count exact numbers without medical testing, research and fertility experts offer general estimates. At age 30, a woman typically has between 100,000 and 150,000 eggs remaining in her ovarian reserve—far more than she’ll ever use, but still a finite number.

By age 35, that reserve often drops to around 80,000 eggs, though individual variation is significant. This decline is part of a natural process: women are born with all the eggs they’ll ever have—about 1 to 2 million at birth—and that number steadily decreases over time, accelerating in the mid- to late-thirties. By the late thirties, the egg count can drop sharply to 25,000 or even fewer, depending on genetics, lifestyle, and overall health.

It’s important to remember that not all eggs are equal. Egg quality, not just quantity, plays a crucial role in fertility and pregnancy outcomes. As women age, the chances of chromosomal abnormalities increase, which can impact the ability to conceive and carry a pregnancy to term. However, many women in their mid-thirties and beyond go on to have healthy pregnancies—some naturally, others with the help of fertility support.

While the numbers may seem concerning, they’re just one piece of the puzzle. Understanding your reproductive health through conversations with a doctor, tracking menstrual regularity, and considering early testing if planning for later parenthood can all empower more informed decisions. Age is just one factor—and for many, it’s far from the final word.

Read more →

The Secret to Youthful Skin? Retinol.

When it comes to turning back the clock on aging skin, one ingredient consistently rises to the top: retinol. Dermatologists widely regard it as the gold standard in anti-aging skincare, and for good reason. As Dr. Dennis Gross, a board-certified dermatologist, explains, “Retinol is a powerhouse anti-aging ingredient that works to stimulate cell turnover and increase our skin's natural collagen production in the epidermis and dermis.”

Over time, our skin’s natural renewal process slows down. Dead cells linger on the surface, leading to a dull, uneven complexion, while collagen—the protein responsible for firmness and elasticity—declines. Retinol, a form of vitamin A, steps in to revitalize this process. It accelerates exfoliation, revealing fresher, brighter skin underneath, while also signaling deeper layers to produce more collagen. The result? Smoother texture, reduced fine lines, and a more youthful glow.

What makes retinol stand out is its proven track record. Unlike many trendy skincare ingredients, it's backed by decades of clinical research. However, it’s not without its quirks. New users may experience dryness or irritation, especially at first. Dermatologists recommend starting slowly—using it every other night—and pairing it with a gentle moisturizer to ease the transition.

Today, retinol is available in various formulations, from over-the-counter serums to prescription-strength retinoids like tretinoin. While the latter are more potent, even milder retinol products can deliver noticeable improvements with consistent use. For best results, apply at night and always wear sunscreen during the day, as retinol can make skin more sensitive to UV damage.

In a crowded market of anti-aging promises, retinol remains a tried-and-true champion. If you're looking for one ingredient to simplify your routine and deliver real results, this vitamin A derivative is hard to beat.

Read more →

The Drawback of Rapamycin in Cancer Treatment

While rapamycin and its derivative everolimus have shown promise in targeting specific pathways involved in cancer growth, they’re not without side effects. One notable disadvantage, particularly at higher doses, is the development of hyperglycemia—elevated blood sugar levels—observed in some cancer patients undergoing treatment.

This increase in blood glucose is typically mild, categorized as grade 1-2 in clinical terms, and importantly, reversible. Unlike chronic diabetes, this condition doesn’t usually require stopping treatment. It’s considered a metabolic side effect linked to the drug’s mechanism rather than a sign of true diabetes onset. Still, it calls for careful monitoring, especially in patients with pre-existing glucose concerns.

Hyperglycemia isn’t unique to rapamycin—it’s a known effect of several targeted cancer therapies. The mTOR pathway, which rapamycin inhibits to slow tumor growth, also plays a role in insulin signaling. Disrupting this pathway can impair glucose regulation, leading to transient spikes in blood sugar. However, because these changes are generally manageable, they rarely interfere with a patient’s ability to continue therapy.

That said, awareness is key. Oncologists often assess metabolic health before and during treatment, adjusting as needed through diet, lifestyle, or short-term medications. The goal is to balance efficacy with tolerability, ensuring patients receive the full benefit without unnecessary complications.

In the broader picture, while hyperglycemia remains a recognized downside of high-dose rapamycin, its mild and reversible nature means it’s often outweighed by the drug’s anti-cancer potential. With proper oversight, most patients can navigate this side effect smoothly, staying on track toward recovery.

Read more →